Clinical Trial Update: Benefits and Risks of Newborn Screening for Cystic Fibrosis [NA]

View source ↗

Summary

This completed trial evaluated the benefits and risks of newborn screening for cystic fibrosis and its impact on early detection, lung disease progression, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Pseudomonas Infection

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Cystic Fibrosis, Lung Disease | NA | Status: COMPLETED